Alzheimer’s Research
A top Alzheimer’s researcher addresses many of the basic questions that are key to understanding this challenging disease.
We Work for Health
- Coalition partners
- Counterfeit Medicines: Q&A with Pfizer’s Chief Security Officer
- PhRMA Applauds G8 Action on Anti-Counterfeiting
- PhRMA Applauds G8 Action on Anti-Counterfeiting
- The U.S. currently leads the world in medical innovation. But for how long?
- The Future Looks Gray
- Alzheimer’s and Clinical Trials
- New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
- Pharmaceutical Sector Tops Philanthropic Giving List
- This Sunday is Mother’s Day – Take a Moment to Remember, Say Thanks
- Castellani to Talk about Global Aging Populations and Healthcare Costs
- Forget to Take Part in DEA National Take Back Day? Other Safe Disposal Options for Rx Meds Are Available
- PhRMA Urges President Obama to Secure an Ambitious Trans-Pacific Partnership Agreement
- Join the Conversation With @RepAnnaEshoo: #SafeMedsForKids
- What to Watch: A Primer on PDUFA
- FDA Commissioner Checks in on Drug Shortages Progress, Likes What She Sees
- FDA Commissioner Checks in on Drug Shortages Progress, Likes What She Sees
- PhRMA Statement on Special 301 Report
- World Asthma Day: "You Can Control Your Asthma"
- Asthma at Home
- Controlling Asthma
